Herein, to map changes in protein levels associated with metabolic signature, we integrated label-free quantitative proteomic analysis, transcriptomic data, and metabolic activity assays, aiming to search for CD34+ leukemia cell-specific metabolic vulnerabilities for therapeutic purpose. Here, CD34 is linked to leukemia.